The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysis.

Nevertheless, we cannot assert the significance of survival benefits for male patients receiving ICI, as the p value for interaction did not reach statistical significance ( p interaction = 0.117). 4 DISCUSSION Despite the accumulating evidence suggesting a favorable association between high BMI and clinical outcomes in individuals receiving ICI therapy, the current literature remains limited in terms of its ability to substantiate this observation specifically in patients with mUC.

also in 111,027 other papers